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SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for molybdenum
1
 
EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly 
absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the regulation of 
excretion via the urine. Molybdenum deficiency in otherwise healthy humans has not been observed and there are 
no biomarkers of molybdenum status. Various metabolic balance studies have been performed to establish 
molybdenum requirements. However, only one balance study, which was performed with a constant diet and 
under controlled conditions in adult men, was considered to be of sufficient duration. In this small study, balance 
was reported to be near zero when molybdenum intakes were 22 µg/day. Biochemical changes or symptoms 
suggestive of molybdenum deficiency were not observed, and it is possible that humans may be able to achieve 
molybdenum balance at even lower intakes. Data on molybdenum intakes and health outcomes were unavailable 
for the setting of DRVs for molybdenum. As the evidence required to derive an Average Requirement and a 
Population Reference Intake was considered insufficient, an Adequate Intake (AI) is proposed. Observed 
molybdenum intakes from mixed diets in Europe were taken into consideration in setting this value. An AI of 
65 µg/day is proposed for adults; a figure that is based on molybdenum intakes at the lower end of the wide range 
of observed intakes. It is suggested that the adult AI also applies to pregnant and lactating women. An AI is also 
proposed for infants from seven months and for children based on extrapolation from the adult AI using isometric 
scaling and the reference body weights of the respective age groups.   
© European Food Safety Authority, 2013 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a scientific opinion on Dietary Reference Values (DRVs) 
for the European population, including molybdenum.  
Molybdenum is an essential component of certain enzymes that catalyse redox reactions and contain, 
in addition to molybdenum, other prosthetic groups such as flavin adenine dinucleotide or haem. In 
humans, sulphite oxidase, xanthine oxidoreductase, aldehyde oxidase and mitochondrial amidoxime 
reducing component require molybdenum linked with a pterin (molybdopterin) as the cofactor. These 
enzymes are involved in the metabolism of aromatic aldehydes and the catabolism of sulphur-
containing amino acids and heterocyclic compounds, including purines, pyrimidines, pteridins and 
pyridines. 
In humans, a single case report of a syndrome suggestive of dietary molybdenum deficiency in a 
patient on total parenteral nutrition for several months has been reported, but clinical signs of 
molybdenum deficiency in otherwise healthy humans have not been observed. A distinct molybdenum 
deficiency syndrome has not been observed in animals when subjected to molybdenum restriction, 
despite considerable reduction in the activity of molybdoenzymes.  
Water-soluble molybdates are efficiently and rapidly absorbed from the digestive tract at a wide range 
of intakes, and the body is able to adapt to this wide intake range by regulating excretion via the urine. 
Storage of molybdenum in mammals is low, and most tissue molybdenum is thought to be associated 
with molybdoenzymes. 
There are no suitable biomarkers of molybdenum status. Biochemical changes observed in subjects 
with molybdopterin cofactor deficiency, a genetic disorder, or in the one subject reported with 
possible molybdenum deficiency, have not been observed in healthy individuals on varying levels of 
molybdenum intake. Low activity of molybdoenzymes in tissues, or changes in substrate/product 
relationships, are considered as insufficiently specific to be used as biomarkers of status.  
Molybdenum is present in nearly all foods in trace amounts as soluble molybdates. Foods high in 
molybdenum are pulses, cereal grains and grain products, offal (liver, kidney) and nuts. Cereals and 
cereal-based products including bread are the major food contributors to the dietary molybdenum 
intake of adults. Mean molybdenum intakes, as assessed in duplicate diet or food portion studies, total 
diet studies and market basket studies, vary over a wide range, i.e. 58 µg/day to 157 µg/day, for adults 
in various European countries. Mean intakes are at or above 100 µg/day in five of the eight European 
countries for which data are available. Molybdenum intakes of children are only available from two 
European countries. 
In 1993, the Scientific Committee for Food did not publish DRVs for molybdenum. More recently, 
other authorities have set DRVs for molybdenum and these are based on the maintenance of 
molybdenum homeostasis as measured in balance studies, taking into account molybdenum 
bioavailability from various food sources, or are based on observed molybdenum intakes with a mixed 
diet. 
Various balance studies have been performed to establish molybdenum requirements. However, only 
one balance study in adults was considered to be of sufficient duration, and was performed with a 
constant diet and under controlled conditions. In this study carried out in four men, balance was 
reported to be near zero from day 49 until day 102 of the depletion period when intakes were as low 
as 22 µg/day. Biochemical changes or symptoms suggestive of molybdenum deficiency were not 
observed and the possibility that humans may be able to achieve molybdenum balance at even lower 
intakes cannot be excluded. Results of two balance studies with some methodological limitations were 
reported in children, but these studies cannot be used to derive an average molybdenum requirement 
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for children. Data on molybdenum intakes and health outcomes were unavailable for the setting of 
DRVs for molybdenum. 
As the evidence to derive an Average Requirement (AR), and thus a Population Reference Intake, was 
considered insufficient, an Adequate Intake (AI) is proposed. An AI of 65 µg/day is proposed for 
adult men and women based on mean molybdenum intakes at the lower end of the wide range of 
observed intakes from mixed diets in Europe. Given the scarcity of data on molybdenum intakes in 
pregnant and lactating women, it is suggested that the adult AI also applies to pregnant and lactating 
women. For infants from seven months and children, it was decided that an AR could not be 
established, and an AI is proposed based on extrapolation from the adult AI using isometric scaling 
and reference body weights of the respective age groups. The respective AIs vary between 10 µg/day 
in infants aged 7-11 months and 65 µg/day in adolescent boys and girls.  
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European 
Community dates from 1993. There is a need to review and if necessary to update these earlier 
recommendations to ensure that the Community action in the area of nutrition is underpinned by the 
latest scientific advice.  
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European 
Community
4
. The report provided Reference Intakes for energy, certain macronutrients and 
micronutrients, but it did not include certain substances of physiological importance, for example 
dietary fibre. 
Since then new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on 
recommended dietary intakes. For a number of nutrients these newly established (national) 
recommendations differ from the reference intakes in the SCF (1993) report. Although there is 
considerable consensus between these newly derived (national) recommendations, differing opinions 
remain on some of the recommendations. Therefore, there is a need to review the existing EU 
Reference Intakes in the light of new scientific evidence, and taking into account the more recently 
reported national recommendations. There is also a need to include dietary components that were not 
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be 
appropriate to establish reference intakes for other (essential) substances with a physiological effect. 
In this context, EFSA is requested to consider the existing Population Reference Intakes for energy, 
micro- and macronutrients and certain other dietary components, to review and complete the SCF 
recommendations, in the light of new evidence, and in addition advise on a Population Reference 
Intake for dietary fibre.  
For communication of nutrition and healthy eating messages to the public it is generally more 
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context, EFSA is asked to provide assistance on the translation of nutrient based 
recommendations for a healthy diet into food based recommendations intended for the population as a 
whole.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) and Article 31 of Regulation (EC) No. 178/2002, the 
Commission requests EFSA to review the existing advice of the Scientific Committee for Food on 
population reference intakes for energy, nutrients and other substances with a nutritional or 
physiological effect in the context of a balanced diet which, when part of an overall healthy lifestyle, 
contribute to good health through optimal nutrition.  
In the first instance the EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically, advice is requested on the following dietary components:  
 Carbohydrates, including sugars; 
 Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty 
acids, trans fatty acids; 
                                                     
4  Scientific Committee for Food, Nutrient and energy intakes for the European Community, Reports of the Scientific 
Committee for Food 31st series, Office for Official Publication of the European Communities, Luxembourg, 1993. 
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 Protein; 
 Dietary fibre. 
Following on from the first part of the task, EFSA is asked to advise on population reference intakes 
of micronutrients in the diet and, if considered appropriate, other essential substances with a 
nutritional or physiological effect in the context of a balanced diet which, when part of an overall 
healthy lifestyle, contribute to good health through optimal nutrition. 
Finally, EFSA is asked to provide guidance on the translation of nutrient-based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal 
nutrition (food-based dietary guidelines). 
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ASSESSMENT 
1. Introduction 
Molybdenum is required as a component of enzymes involved in the catabolism of sulphur amino 
acids and heterocyclic compounds, as well as in the metabolism of aromatic aldehydes. Because of its 
role in metabolism, molybdenum is considered an essential dietary element for mammals, though 
clinical signs of dietary molybdenum deficiency in otherwise healthy humans have not been 
described. In 1993, the Scientific Committee for Food did not publish Dietary Reference Values 
(DRVs) for molybdenum (SCF, 1993), but more recently other authorities have set DRVs for 
molybdenum. 
2. Definition/category 
2.1. Chemistry 
Molybdenum (Mo) is a transition metal with an atomic mass of 95.96 Da. It exists in several oxidation 
states, the most stable being +4 and +6. Molybdenum is widely distributed in nature, the abundance in 
the earth‟s crust being about 1-1.5 mg molybdenum/kg (SCF, 2000; Eckhert, 2006). It is ubiquitous in 
food and water as soluble molybdates (Mo(VI)O4
2-
).  
2.2. Functions of molybdenum 
2.2.1. Biochemical functions 
Molybdenum-containing enzymes catalyse redox reactions and are found in many plants and animal 
organisms. As a consequence of the easy interconvertibility of different oxidation states (Mo
4+
/Mo
6+
), 
molybdenum-containing enzymes have the ability to provide electron transfer pathways. In addition to 
molybdenum, they also contain other prosthetic groups such as flavin adenine dinucleotide or haeme 
(Rajagopalan, 1988). In humans, sulphite oxidase, xanthine oxidoreductase, aldehyde oxidase and 
mitochondrial amidoxime reducing component require molybdenum linked with a pterin 
(molybdopterin) as cofactor (Reiss and Hahnewald, 2011). These enzymes are involved in the 
catabolism of sulphur-containing amino acids and heterocyclic compounds, including purines, 
pyrimidines, pteridins and pyridines, and in the metabolism of aromatic aldehydes. 
2.2.2. Health consequences of deficiency and excess 
2.2.2.1. Deficiency 
A distinct molybdenum deficiency syndrome has not been described in animals when subjected to 
molybdenum restriction, despite considerable reduction in the activity of molybdoenzymes. For 
example, using low-molybdenum diets and administration of tungsten in drinking water, the activity 
of rat liver xanthine oxidase was decreased to 10 % of its normal value without changing the 
excretion of uric acid or allantoin or otherwise affecting the health of the animals. Likewise, adult rats 
with less than 3 % residual liver sulphite oxidase activity remained healthy and showed no signs of 
neurological damage (Cohen et al., 1973; Johnson et al., 1974).  
In humans, there is one published case report of a syndrome suggestive of dietary molybdenum 
deficiency. A 24-year-old male patient with Crohn‟s disease and short bowel syndrome was on total 
parenteral nutrition (TPN) lacking in molybdenum for 12 months, at which point he developed a 
syndrome characterised by tachycardia, tachypnea, severe headache, nausea and vomiting, night 
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blindness, and central scotomas, which progressed to oedema, lethargy, disorientation and coma. 
These symptoms were associated with high plasma methionine and low serum uric acid 
concentrations, as well as reduced urinary concentrations of sulphate, thiosulphate, and uric acid. 
Whilst modification of the TPN solution by lowering the sulphur load was ineffective, treatment with 
ammonium molybdate (300 µg/day)
5
 resulted in considerable improvement of the clinical symptoms 
and progressive reversal of the biochemical abnormalities within 30 days (Abumrad et al., 1981). 
Clinical signs of molybdenum deficiency in otherwise healthy humans have not been observed. 
Molybdenum cofactor deficiency, a rare autosomal recessive syndrome with a defective hepatic 
synthesis of molybdenum cofactor, results in deficiency of all molybdoenzymes in humans. This 
genetic defect, for which three subtypes are known according to the gene affected, has been found in a 
variety of ethnic groups and all over the world (Reiss and Hahnewald, 2011). It is associated with 
feeding difficulties and seizures starting shortly after birth, neurological and developmental 
abnormalities, mental retardation, encephalopathy, ectopy of the lens and usually death at an early 
age, though the successful treatment of one affected child with molybdenum cofactor deficiency type 
A using the first detectable intermediate substance in the biosynthesis pathway of molybdenum 
cofactor has recently been reported (Veldman et al., 2010; Mendel and Kruse, 2012). In untreated 
patients, plasma concentrations of urate are low, urinary concentrations of sulphite, thiosulphate and 
S-sulpho-L-cysteine are increased, and urinary urate and sulphate concentrations are decreased.  
2.2.2.2. Excess 
The Scientific Committee on Food (SCF) has set a Tolerable Upper Intake Level (UL) based on 
adverse effects of molybdenum on reproduction, particularly fetal development, shown in studies with 
rats and mice, from which a No Observed Adverse Effect Level (NOAEL) of 0.9 mg/kg body weight 
per day was derived. Using an uncertainty factor of 100, a UL of 0.01 mg/kg body weight per day, 
equivalent to 0.6 mg/day, was derived for adults, including pregnant and lactating women. For 
children from one year of age onwards, the UL was extrapolated from the adult UL on a body weight 
basis, and was set at between 0.1 and 0.5 mg/day (SCF, 2000).  
2.3. Physiology and metabolism of molybdenum 
2.3.1. Intestinal absorption 
Water-soluble molybdates are readily absorbed from the digestive tract. Balance studies with stable 
isotopes have shown that molybdenum is efficiently and rapidly absorbed at a wide range of intakes, 
indicating that molybdenum absorption is passive and not saturable, and that it is not regulated at the 
level of intestinal absorption (Turnlund et al., 1995b).  
At doses up to about 1 mg, molybdenum dissolved in water is completely absorbed into the systemic 
circulation. Molybdenum absorption in the presence of solid foods (cress, green salad, tomatoes, bean 
soup) is lower compared to administration with water (Giussani et al., 2006; Giussani et al., 2007). 
When added to a beverage containing starch, dextrimaltose, oil, sucrose, α-cellulose and minerals, the 
absorption efficiency of increasing doses of 
100
Mo ranging from 24 to 1 378 µg was between 90 and 
94 % in healthy men (Novotny and Turnlund, 2006, 2007). Black tea has been shown to considerably 
reduce molybdenum absorption upon ingestion of relatively high amounts of molybdenum (0.5-1 mg 
as a single dose of stable isotope) (Giussani et al., 2006; Giussani et al., 2007). In ten premature 
infants, absorption of the stable isotope 
100
Mo from infant formula was 97.5 % (96.3-99.1 %) after 
receiving 25 µg molybdenum/kg body weight (Sievers et al., 2001). 
                                                     
5  Reported as such by Abumrad et al. (1981), without additional information (e.g. molecular weight) of the compound used. 
Others have interpreted this as a molybdenum dose of 147 µg/day (WHO, 1996) or 300 µg/day (Rajagopalan, 1988). 
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Studies using kale or soy intrinsically labeled with stable isotopes of molybdenum have shown that 
molybdenum absorption was 86.1 % and 56.7 %, respectively, from meals with either kale or soy 
casseroles containing about 100 µg molybdenum. Molybdenum absorption from an extrinsic label 
also added to the meals was 87.5 %. When the molybdenum content of the meal was increased to 
about 310 µg in a subsequent study, molybdenum absorption from soy amounted to 58.3 %, and 
molybdenum absorption from the extrinsic label was 92.8 % (Turnlund et al., 1999).  
Using a compartmental model based on a molybdenum depletion-repletion study in four men, the 
mean bioavailability of molybdenum from the experimental diet was predicted to be 76 % (Novotny 
and Turnlund, 2006). A slightly higher bioavailability of 83 % for food-bound molybdenum was 
predicted with the compartmental model, based on a study which gave the same three-day rotating 
diet regimen but with five different molybdenum contents consecutively for 24 days each to four men 
(Novotny and Turnlund, 2007).   
Little is known about the mechanism of molybdenum absorption and the site of absorption in the 
gastrointestinal tract. In animals, Mo(VI) but not Mo(IV) is readily absorbed from the duodenum and 
proximal jejunum (SCF, 2000). Recently, a family of proteins probably related to molybdate transport 
in animals and humans has been described, though the exact location of this high-affinity transporter 
within the cell has not yet been identified (Tejada-Jimenez et al., 2011; Mendel and Kruse, 2012). It is 
assumed that in addition to a possible high-affinity uptake system, molybdate may also enter the cell 
nonspecifically through the sulphate uptake system, which has been shown to be present in plants 
(Fitzpatrick et al., 2008). 
Tungsten is known to inhibit molybdenum uptake, and this inhibitory effect has been used in animal 
studies to induce molybdenum deficiency, but it is not considered relevant for humans because of the 
rare occurrence of tungsten in the environment and consequently in the food chain (Cohen et al., 
1973; Johnson et al., 1974; Rajagopalan, 1988; Eckhert, 2006). In sheep and rats, high sulphate 
intakes have been shown to inhibit molybdenum absorption, suggesting that both sulphate and 
molybdenum share a common transport mechanism (Eckhert, 2006). An interaction with copper has 
been observed leading to copper deficiency in sheep exposed to high molybdenum intake. In 
ruminants, excessive intakes of molybdenum lead to formation of thiomolybdate in the sulphide-rich 
environment of the rumen; thiomolybdate (a molecule where sulphur groups surround a molybdenum 
centre) is a chelator of copper ions, thereby inhibiting copper absorption (Nederbragt et al., 1984). By 
contrast, in humans, clinical symptoms of copper deficiency are largely confined to individuals with 
rare genetic defects in copper metabolism (Suttle, 2012). In four adult males on two sorghum diets 
providing daily 2.4 mg of copper and 166 µg or 540 µg of molybdenum, respectively, faecal copper 
excretion was comparable and apparent copper absorption unaffected by molybdenum intake 
(Deosthale and Gopalan, 1974).  
2.3.2. Transport in blood 
In animals and humans, little is known about proteins involved in molybdenum transport (Llamas et 
al., 2011). Specific binding to α-2-macroglobulin, but not to albumin, has been shown in in vitro 
studies after incubation of human serum with 
99
Mo (Kselikova et al., 1977), though it is thought that 
the fraction bound to α-2-macroglobulin is small and that most molybdenum remains in the blood as 
molybdate (MoVI) which does not bind to α-2-macroglobulin (Bibr et al., 1985). Part of the 
molybdenum in the blood is transported in erythrocytes after uptake through a membrane anion 
exchanger (Gimenez et al., 1993). In erythrocytes, most molybdenum is protein-bound (IOM, 2001).  
Molybdenum concentrations in plasma measured with more sensitive and accurate techniques (ICP-
MS) have been reported to range between 3-11 nmol/L in people with usual molybdenum intakes 
(Turnlund and Keyes, 2004). 
Dietary Reference Values for molybdenum 
 
EFSA Journal 2013;11(8):3333 11 
Intravenously infused molybdenum disappears rapidly from the blood; depending on the tracer dose 
given, the plasma tracer concentration was approximately halved or even lower within two hours after 
injection (Cantone et al., 1995; Giussani et al., 2006).  
2.3.3. Distribution to tissues 
The highest molybdenum concentrations are found in the liver and kidney. In adults, the liver  
contains 1.3-2.9 mg molybdenum/kg dry matter, the kidney 1.6 mg/kg dry matter, the lung 0.15 mg/kg 
dry matter, the brain and muscle 0.14 mg/kg dry matter (WHO, 1996), and for hair concentrations of 
0.03 mg/kg (Ochi et al., 2011) have been reported. Total body molybdenum of a “standard man” was 
calculated to be about 2.3 mg after analysis of tissues from 150 accidental deaths (Schroeder et al., 
1970), and about 2.2 mg with the use of a compartmental model and fractional transfer coefficients 
observed at a molybdenum intake of 121 µg/day given for 24 days, and which was considered to be in 
line with the habitual molybdenum intake of participants prior to the study (Novotny and Turnlund, 
2007).  
2.3.4. Storage 
Storage of molybdenum in mammals is low. Most tissue molybdenum is thought to be associated with 
molybdoenzymes, as indicated by the reported absence of detectable molybdenum in the liver tissue 
of molybdenum cofactor-deficient patients (Rajagopalan, 1988).  
In the liver of fetuses (age: 23 weeks of gestation to term), molybdenum concentrations were more 
than seven-fold lower compared to adults (Meinel et al., 1979), and such differences have 
subsequently been interpreted as the absence of molybdenum stores and a low fetal molybdenum 
requirement (Abramovich et al., 2011).  
2.3.5. Metabolism 
In order to fulfill its biological role, molybdenum must enter the cell and be assembled into a 
molybdenum cofactor. In eukaryotes, the molybdate transport process and the proteins involved are 
not fully understood (Llamas et al., 2011). 
Molybdenum cofactor is synthesised in the cytosol by a conserved biosynthetic pathway that can be 
divided into four main steps. In the final step of molybdenum cofactor biosynthesis, a single 
molybdenum ion is bound to one or two molybdopterin dithiolates. After completion of biosynthesis, 
mature molybdenum cofactor has to be inserted into molybdoenzymes. A molybdenum cofactor 
carrier protein has been described in the green alga Chlamydomonas rheinhardtii, but information is 
lacking for other eukaryotes (Llamas et al., 2006). The formation of active molybdoenzymes depends 
not only on the availability of molybdenum but also on the presence of iron, zinc and copper (Llamas 
et al., 2011). 
2.3.6. Elimination 
2.3.6.1. Kidney 
Absorbed molybdenum is rapidly excreted via the kidney, and whole body retention is regulated 
primarily by urinary excretion. Depending on the dose of stable isotope (
95
Mo or 
96
Mo) injected, 34 % 
to about 60 % of the injected tracer was excreted in the urine within one day, and between 42 and 
about 70 % within five days, following its injection (Werner et al., 2000). Studies using different 
doses of molybdenum intake have shown that about 60 % of the total amount of molybdenum 
excreted was via the urine when dietary molybdenum intake was very low (22 µg/day), whereas the 
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proportion excreted via the urine increased to more than 90 % when dietary molybdenum intake was 
high (467 µg/day or up to 1 488 µg/day) (Turnlund et al., 1995b; Turnlund et al., 1995a). When 
dietary molybdenum intake is low, mechanisms such as an increased fractional transfer from plasma 
to tissues act to reduce urinary molybdenum excretion and to conserve body molybdenum (Turnlund 
et al., 1995b; Novotny and Turnlund, 2006, 2007).  
2.3.6.2. Faeces 
Molybdenum excretion via the faeces is low. Upon oral ingestion of the stable isotope 
100
Mo (at doses 
increasing from 23.8 µg to 1 378 µg) by four young men, an average of between 7.3 and 12.3 % of the 
dose fed was excreted in their faeces in the 12 days after each dose (Turnlund et al., 1995b). 
2.3.6.3. Breast milk 
Molybdenum concentrations in human milk sampled at various stages of lactation are shown in 
Appendix A and these include eight studies on human milk molybdenum concentrations from women 
residing in the EU. Only one study measured maternal molybdenum intake (132 ± 60 µg/day). This 
study on 19 women did not find a correlation between maternal molybdenum intake and breast milk 
concentration (Wappelhorst et al., 2002). For all studies shown in Appendix A and including 
colostrum, transitory and mature human milk, the concentration of molybdenum was highly variable 
ranging from 0.001 to 63 µg/L, with mean values from 0.348 to 24 µg/L.  
Molybdenum concentrations of human milk appear to be highest during the first few days of 
breastfeeding, and decrease during the course of lactation (Dang et al., 1984; Casey and Neville, 
1987; Bouglé et al., 1988; Aquilio et al., 1996; Krachler et al., 1998; Friel et al., 1999) (Appendix A). 
In mature human milk
6
 from women in Europe, mean molybdenum concentrations were reported to 
range from 0.72 to 4 µg/L.  
2.4. Biomarkers  
2.4.1. Biomarkers of intake 
Plasma molybdenum concentrations reflect longer-term molybdenum intake, but 24-hour urinary 
excretion is more directly related to recent intake and appears to be a suitable biomarker of short term 
molybdenum intake (Turnlund and Keyes, 2004). 
2.4.2. Biomarkers of status 
Biochemical changes observed in subjects with genetic molybdopterin cofactor deficiency or in the 
one subject with molybdenum deficiency (low urinary and serum uric acid, elevated plasma 
methionine, high urinary excretion of hypoxanthine and xanthine, abnormal excretion of sulphur 
metabolites) have not been observed in healthy individuals on varying levels of molybdenum intake 
(Turnlund et al., 1995b; Turnlund et al., 1995a).  
Low activity of molybdoenzymes in tissues (e.g. of xanthine dehydrogenase) or changes in 
substrate/product relationships are considered as insufficiently specific to be used as biomarkers of 
status, as they are also influenced by the intake of other dietary components such as protein/amino 
acids (WHO, 1996).  
The Panel concludes that there is no useful biomarker of molybdenum status.    
                                                     
6  Mature human milk is usually defined as human milk obtained after 14 days of lactation (Montagne et al., 2001). 
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3. Dietary sources and intake data 
3.1. Dietary molybdenum sources 
Molybdenum is present in nearly all foods in trace amounts as soluble molybdates. Foods high in 
molybdenum are pulses, cereal grains and grain products, offal (liver, kidney) and nuts (Pennington 
and Jones, 1987; Rajagopalan, 1988; Rose et al., 2010; Anses, 2011). Molybdenum is an essential 
micronutrient required by plants (Fitzpatrick et al., 2008). The molybdenum content in plant-based 
foods varies greatly and depends on the properties of the soil where the foods are grown; 
molybdenum uptake by plants is promoted by neutral or alkaline soils (WHO, 1996). Molybdenum 
concentrations in drinking water are usually below 10 μg/L, although concentrations as high as 
200 µg/L have been reported in areas near mining sites (WHO, 2008).  
Currently, potassium molybdate (MoVI) may be added to food supplements
7
, whereas ammonium 
molybdate (MoVI) and sodium molybdate (MoVI) may be added to both foods
8
 and food 
supplements
7
. 
Results from Total Diet Studies (TDS) in Western countries including France and the UK have shown 
that cereals and cereal-based products including bread are the major food contributors to dietary 
molybdenum intake of adults and such sources contribute about one third to one half of total 
molybdenum intake. Further contributors to molybdenum intake are dairy products and vegetables 
(Pennington and Jones, 1987; Rose et al., 2010; Anses, 2011; NFA, 2012; FSANZ, online). Foods 
contributing to molybdenum intake in France, UK and Sweden are shown in Appendix B. 
3.1.1. Infant and follow-on formula 
In a report on the essential requirements of infant and follow-on formulae, the SCF did not define a 
minimum or maximum content of molybdenum for either type of formulae (SCF, 2003). Compared to 
mature human milk, cow‟s milk has a higher molybdenum concentration (34 µg/kg as reported by 
Rose et al. (2010), mean of 46 µg/kg as reported by Anses (2011)). Hence, the molybdenum content 
of cow‟s milk based-infant formula is higher compared to mature human milk. For 81 powdered 
cow‟s milk-based or soy-based infant formulae from the US and Canada, molybdenum concentrations 
ranged from 15.4 to 80.3 μg/L (mean ± SE, 37.7 ± 1.7 μg/L) (Abramovich et al., 2011).  
3.2. Dietary molybdenum intake in children and adults 
Reports of usual dietary molybdenum intakes vary widely because of differences in analytical 
methods and in the molybdenum content of the soils in which foods are grown. National food 
consumption surveys usually do not report on molybdenum intake because of lack of information on 
molybdenum in food composition databases.  
Appendix C shows dietary molybdenum intakes of adults, children or the total population in various 
European countries where molybdenum intakes have been assessed using duplicate diet/portion 
sampling, the total diet approach or the market basket approach to provide information about total 
dietary exposure. Results show that mean molybdenum intakes of adults vary over a wide range, i.e. 
from 58 µg/day (German women in four regions of Eastern Germany) to 157 µg/day (Sweden). Mean 
intakes are at or above 100 µg/day in five of the eight European countries for which data are 
available. Average molybdenum intakes assessed in duplicate diet or food portion studies range 
between 58 µg/day (Germany) and 112 µg/day (Denmark), while they are between 79.6 and 
                                                     
7  Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements, OJ L 183, 12.7.2002, p. 51. 
8  Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods, OJ L 404, 30.12.2006, p. 26. 
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125 µg/day in three total diet studies (Italy, France, UK). The Italian study used a modified TDS 
approach in which analysed molybdenum contents of local foods of only one region in Northern Italy 
were used in the calculations. Minimum intakes range between 20 µg/day (Denmark) and 86 µg/day 
(Finland), with the intake at the 5
th
 percentile being 49.1 µg/day in France. Maximum intakes range 
between 89.1 µg/day (Belgium) to 560 µg/day (Denmark), with the intake at the 95
th
 percentile being 
155 µg/day in France. 
Data on molybdenum intakes in pregnant women are not available. In lactating women, there is only 
one study on 19 women, which reported a mean molybdenum intake of 132 ± 60 µg/day (see Section 
2.3.6.3). 
In children, mean intakes were reported to be 74.9 µg in France (3-17 years), and about 3 µg/kg body 
weight per day (4-18 years) and 4.8 µg/kg body weight per day (1.5-4.5 years) in the UK. Intakes at 
the lower (P5) and upper (P95) end were 40.3 µg/day and 130 µg/day, respectively, in French children 
(3-17 years). 
4. Overview of Dietary Reference Values and recommendations 
4.1. Adults 
The German-speaking countries (D-A-CH, 2013) set an Adequate Intake (AI) of 50-100 µg/day based 
on molybdenum intakes with a mixed diet.  
The US Institute of Medicine (IOM, 2001) derived an average requirement based on a molybdenum 
balance study with four young males by Turnlund et al. (1995a). Average molybdenum balance was 
achieved with an intake of 22 µg/day, and no clinical signs of deficiency or biochemical changes 
associated with molybdenum deficiency were observed. The average minimum molybdenum 
requirement for maintaining adequate molybdenum status was estimated to be 22 μg/day, to which an 
additional 3 μg/day was added to allow for miscellaneous losses. In addition, it was assumed that 
molybdenum bioavailability from some diets may be lower than from the diet provided in the study. 
Thus, an average bioavailability of 75 % was used to set an Estimated Average Requirement (EAR) of 
34 μg/day. Because of the use of only two different molybdenum intake levels and the small size of 
the study, IOM used a coefficient of variation (CV) of 15 % and derived a Recommended Dietary 
Allowance (RDA) of 45 µg/day as the EAR plus twice the CV to cover the needs of 97 to 98 % of the 
individuals in the group. As no data on which to base an EAR were found for women or older adults, 
the same values were given for these population groups (IOM, 2001).  
The UK Committee on Medical Aspects of Food Policy (COMA) did not derive a Recommended 
Nutrient Intake (RNI) for molybdenum but set a safe intake range of 50-400 µg/day. The range is 
based on intakes of apparently healthy subjects in various Western countries (DH, 1991). 
The Nordic countries (NNR, 2004), WHO/FAO (2004), the Scientific Committee for Food (SCF, 
1993), the Health Council of the Netherlands (2009) and the Agence française de sécurité sanitaire 
des aliments (Afssa, 2001) did not derive DRVs for molybdenum for adults. Afssa considered it 
premature to set DRVs for molybdenum, but considered that the daily requirement for molybdenum 
could be of the order of 25 µg/day (Turnlund et al., 1995a), and that the Population Reference Intake 
(PRI) could be around 30 to 50 µg/day, for adults.  
4.2. Infants and children 
The German-speaking countries (D-A-CH, 2013) set adequate molybdenum intakes for infants and 
children by extrapolating from the AI for adults and taking into account age-specific reference values 
for energy. 
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For children from 7 to 12 months, the IOM (2001) set an AI of 3 µg/day using the weight ratio method 
and extrapolating from the AI for infants aged 0 through 6 months (2 µg/day) exclusively fed human 
milk, as data on the molybdenum content of complementary food consumed in addition to human milk 
were not available. For children and adolescents from 1 to 18 years, IOM extrapolated an EAR from 
the adult EAR using metabolic weight owing to the role of molybdenum as cofactor of several 
enzymes and because this approach resulted in a higher EAR compared to using body weight. The 
same CV as in adults of 15 % was used.  
The UK COMA derived a safe intake range based on evidence from breastfed infants. In the absence 
of other evidence, they suggested similar safe intakes of 0.5-1.5 µg/kg body weight per day for 
children up to 18 years of age (DH, 1991). 
The Nordic countries (NNR, 2004), WHO/FAO (2004), the Scientific Committee for Food (SCF, 
1993), the Health Council of the Netherlands (2009) and Agence française de sécurité sanitaire des 
aliments (Afssa, 2001) did not derive DRVs for molybdenum for infants and children. 
Table 1:  Overview of Dietary Reference Values (DRVs) for molybdenum for infants, children and 
adults 
 
D-A-CH 
(2013) (a) 
IOM 
(2001) (b) 
DH 
(1991) 
Age (months) 4-<12 7-12 - 
DRV (µg/day) 20-40      3 
(a) - 
Age (years) 1-<4 1-3 0-18 
DRV (µg/day) 25-50 17 0.5-1.5 (c) 
Age (years) 4-<7 4-8 - 
DRV (µg/day) 30-75 22 - 
Age (years) 7-<10 9-13 - 
DRV (µg/day) 40-80 34 - 
Age (years) 10-<19 14-18 - 
DRV (µg/day) 50-100 43 - 
Age (years) ≥19 ≥19 ≥19 
DRV (µg/day)  50-100 45 50-400 (d) 
(a):  Adequate Intake 
(b):  Recommended Dietary Allowance 
(c):  Safe intake (range), given as µg/kg body weight per day 
(d):  Safe intake (range) 
4.3. Pregnancy 
The IOM (2001) concluded that no direct data are available for determining the additional daily 
requirement for molybdenum during pregnancy. A weight gain of 16 kg observed in women with good 
pregnancy outcomes was added to the reference weight for non-pregnant adolescent girls and adult 
women, and an EAR was extrapolated using isometric scaling (linear with body weight). Applying a 
CV of 15 % to the EAR of 40 µg/day and rounding to the nearest 10 µg, the RDA was set at 
50 µg/day. 
4.4. Lactation 
The IOM (2001) derived an EAR for lactation as the sum of the molybdenum intake necessary to 
replace the molybdenum secreted daily in human milk and the EAR for adolescent girls and adult 
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women. Based on a daily excretion of 2 μg/day and using a CV of 15 % as well as rounding to the 
nearest 10 µg, the RDA was set at 50 µg/day. 
5. Criteria (endpoints) on which to base Dietary Reference Values 
Current DRVs for molybdenum are based on maintenance of molybdenum homeostasis as measured 
in balance studies, and taking into account molybdenum bioavailability from various food sources, or 
on estimated intakes in adults or exclusively breastfed infants. For other age and life-stage groups, 
reference values were then extrapolated. For lactating women, losses via secretion of milk were also 
taken into account when the average requirement was estimated factorially.  
5.1. Biomarkers of status 
Clinical signs of molybdenum deficiency in otherwise healthy humans have not been observed. There 
are no suitable biomarkers of molybdenum status (see Section 2.3.2.) which can be used to estimate 
molybdenum requirements.  
5.2. Molybdenum balance 
Balance studies are based on the assumption that a healthy subject on an adequate diet maintains an 
equilibrium or a null balance between nutrient intakes and nutrient losses: at this null balance, the 
intake matches the requirement determined by the given physiological state of the individual. When 
intakes exceed losses (positive balance), there is nutrient accretion that may be attributable to growth 
or to weight gain, anabolism or repletion of stores; when losses exceed intakes (negative balance), 
nutrient stores are progressively depleted resulting, in the long term, in clinical symptoms of 
deficiency. When performed at different levels of intakes, balance studies enable the quantification of 
obligatory losses by regression to zero. In addition to numerous methodological concerns about 
accuracy and precision in the determination of intakes and losses (Baer et al., 1999), the validity of 
balance studies for addressing requirements has been questioned: they might possibly reflect only 
adaptive changes before reaching a new steady-state (Young, 1986) or only the conditions for 
maintenance of nutrient stores (Mertz, 1987), or, in the absence of such stores, only activities of 
molybdenum-containing enzymes in the context of a given diet. The relevance of the level of these 
activities for health remains to be established since they can be very low without overt clinical signs 
(see Section 2.2.2.1.). 
5.2.1. Balance studies in adults 
Various balance studies have been performed to establish the molybdenum requirements of adults 
(Tipton et al., 1969; Robinson et al., 1973; Jacobson and Wester, 1977; Turnlund et al., 1995b; 
Turnlund et al., 1995a; Yoshida et al., 2006). However, only a few of these studies were of sufficient 
duration to allow the body to adapt to the level of dietary intake before collecting balance data (at 
least 12 days according to IOM (2001), possibly longer than 24 days (especially for high intakes after 
low intakes) as indicated in the study by Turnlund et al. (1995b), and were performed with constant 
diets and under controlled conditions. 
One such study was a depletion-repletion study, in which four healthy adult men aged 22-29 years 
received a diet containing 22 µg molybdenum/day for 102 days followed by 18 days on the same diet 
but supplemented with ammonium molybdate to provide 467 µg molybdenum/day (Turnlund et al., 
1995a). During the dietary periods, stable molybdenum isotopes were administered intravenously 
(
97
Mo) or orally (
100
Mo) to participants to investigate absorption, retention and excretion. Blood and 
urinary uric acid and urinary sulphite concentrations were periodically measured and no clinical 
symptoms or biochemical changes linked to molybdenum deficiency were observed. Molybdenum 
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concentrations were monitored in urine and faeces. Losses via sweat, saliva and skin could not be 
analysed reliably and were not taken into account. For the first 48 days of the depletion period, mean 
balance based on dietary, urinary and faecal molybdenum was negative. For the following 54 days, 
the average was near zero (0.3 µg/day). After administration of the high dose (467 µg/day) during the 
repletion phase, mean balances were positive for the first two six-day-periods but had returned to 
around baseline (-6.6 µg/day) for the third six-day-period. The Panel notes that despite the careful 
performance of this balance study, part of the molybdenum losses could not be quantified and, 
considering the small scale of the study (n = 4) and the fact that biochemical changes or symptoms 
indicative of molybdenum deficiency were not observed during the depletion period, the possibility 
that humans may be able to achieve molybdenum balance at even lower intakes cannot be excluded.  
When plasma molybdenum concentrations could be reliably measured (see Section 2.2.4.), the data 
from this depletion-repletion study were also used in a compartmental model of molybdenum kinetics 
(Novotny and Turnlund, 2006). In order to model 
100
Mo ingested from foods and total molybdenum in 
plasma, urine and faeces, the model required four compartments, i.e. a stomach, gastro-intestinal, 
plasma, and tissue compartment. For 
97
Mo injected intravenously, two further plasma compartments 
were needed to fit the data. Using the fractional transfer and flow rates observed during the 
molybdenum depletion state, which differed from those observed in the repletion state, an intake of 
43 µg/day was estimated for maintaining the mean plasma molybdenum concentration at baseline 
(9.4 nmol/L). The Panel notes that fractional transfer and flow rates estimated under molybdenum-
sparing conditions were used to predict an intake for a plasma molybdenum concentration that may 
have been the result of a (much) higher intake, and concurrently would have required the use of other 
fractional transfer and flow rates.  
Another balance study used five diets, varying only in molybdenum content. These were given 
consecutively for 24 days each, with total molybdenum intakes starting with 24 µg/day, followed by 
72 µg/day, 122 µg/day, 466 µg/day, and lastly 1 488 µg/day, to four adult men aged 22-33 years 
(Turnlund et al., 1995b). During the first six days of the period with the lowest molybdenum intake 
(24 µg molybdenum/day), balance was highly negative (-46.9 µg/day) but became closer to zero for 
the remaining three six-day-balances of this molybdenum intake level (highest mean balance for six-
day interval, -5.3 µg/day). Thereafter, mean balances were positive for all dietary levels given 
(balances of 1.8 µg/day, 1.3 µg/day, 9.1 µg/day and 103 µg/day, respectively). When dietary 
molybdenum was increased, balances went from positive early in the period to negative by the end of 
the 24-day-period, except in the fourth period. The Panel concludes that the results from this small 
scale study indicate that 24 days were not long enough for the subjects to adapt to the low level of 
molybdenum intake and to conserve tissue molybdenum. The Panel also notes that subjects in this 
study adapted relatively rapidly to ingestion of increasing amounts of molybdenum intakes over a 
wide range, by increasing excretion.  
5.2.2. Molybdenum balance in children 
Two balance studies in children have been published. However, these studies lacked an adaptation 
period, used various diets differing in composition, or measured balances after habitual molybdenum 
intake.  
Alexander et al. (1974) estimated molybdenum balances in eight healthy children aged between three 
months and eight years. Over three days, molybdenum intakes with the habitual diet were estimated 
after analysis of duplicate portions, and urine and faeces were analysed for molybdenum. At 
individual molybdenum intakes between 12 and 65 µg/day and mean intakes of 3.0 ± 0.88 µg/kg body 
weight per day, mean retention was positive (1.27 ± 0.59 µg/kg body weight per day or 42 %).  
Engel et al. (1967) reported on molybdenum balance in girls, aged six to ten years who were given 
various diets differing in amount and type of protein for 6 to 56 days. For each dietary regimen, 3-12 
girls were studied. Mean molybdenum intake with the different diets ranged from 43.2 to 80.8 µg/day, 
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and all diets resulted in positive molybdenum balances (mean balances for intakes from 43.2 to 
47.7 µg/day were between 7.8 and 12.1 µg/24 hours, for intakes from 71.2 to 80.8 µg/day between 2.9 
and 32.6 µg/24 hours; range of individual balances 0.3-36.4 µg/24 hours).  
In addition to the methodological limitations discussed above, these studies did not cover a range of 
molybdenum balances (from negative, through zero or null, to positive) correlated to dietary 
molybdenum intake. Thus, the Panel concludes that these balance studies cannot be used to derive an 
average molybdenum requirement for children. 
5.3. Molybdenum intake and health consequences 
Other criteria based on the functional and health consequences of molybdenum intake may also be 
considered in order to derive DRVs for molybdenum. However, no studies on health outcomes in 
relation to molybdenum intake (from foods or from single-nutrient supplements) were identified 
during the literature review as preparatory work for these DRVs (Mullee et al., 2012). 
6. Data on which to base Dietary Reference Values 
6.1. Adults 
For the reasons outlined in Sections 5.1 and 5.2, the Panel decided that there is insufficient evidence 
to derive an average molybdenum requirement for adults and thus to set a PRI. Therefore, the Panel 
proposes to set an AI.  
For the setting of an adequate molybdenum intake, the Panel considered the observed molybdenum 
intakes from mixed diets in Europe (Appendix C), which were found to vary over a wide range. At the 
lower end of the range, mean molybdenum intakes of 58 µg/day and 74 µg/day were observed in 
women and men, respectively, with the use of the duplicate diet method. Therefore, an AI of 
65 µg/day is proposed for all adults. This approach to setting an AI based on molybdenum intakes at 
the lower end of what has been observed in the EU is supported by evidence from a balance study in 
men on zero molybdenum balance and absence of biochemical changes or symptoms indicative of 
molybdenum deficiency at intakes as low as 22 µg/day for three months (Turnlund et al., 1995a).  
Due to the scarcity of data on molybdenum intakes in pregnant and lactating women, the Panel 
proposes that the AI of 65 µg/day derived for adults should also apply to pregnant and lactating 
women.  
6.2. Infants and children 
No data are available on which to base an average molybdenum requirement for infants and children. 
The Panel decided that an AR cannot be established and proposes an AI extrapolated from the adult 
AI using isometric scaling and the reference body weights of the respective age groups, with rounding 
up to the nearest 5 μg (Table 2).  
For infants aged 7 to 11 months, scaling down from an adult AI and rounding up to the nearest 5 µg 
results in an AI of 10 µg/day.  
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Table 2:  Adequate Intake for molybdenum for infants, children and adults  
Age Reference body weight 
(kg) 
Adequate Intake 
(µg/day) 
  7-11 months      8.6 
(a)
 10 
  1-3   years    11.9 
(b)
 15 
  4-6   years    19.0 
(c)
 20 
  7-10 years    28.7 
(d)
 30 
11-14 years    44.6 
(e)
 45 
15-17 years    60.3 
(f)
 65 
≥ 18 years     63.3 
(g)
 65 
(a):  Mean of body weight-for-age at 50th percentile of male and female infants aged 9 months (WHO Multicentre Growth 
Reference Study Group, 2006) 
(b):  Mean of body weight-for-age at 50th percentile of boys and girls aged 24 months (WHO Multicentre Growth Reference 
Study Group, 2006) 
(c): Mean of body weight at 50th percentile of boys and girls aged 5 years (van Buuren et al., 2012) 
(d): Mean of body weight at 50th percentile of boys and girls aged 8.5 years (van Buuren et al., 2012) 
(e): Mean of body weight at 50th percentile of boys and girls aged 12.5 years (van Buuren et al., 2012) 
(f): Mean of body weight at 50th percentile of boys and girls aged 16 years (van Buuren et al., 2012) 
(g):  Mean of body weight at 50th percentile of 18 to 79-year-old men and women based on measured body heights of 
16 500 men and 19 969 women in 13 EU Member States and assuming a BMI of 22 kg/m2 (see Appendix 11 in EFSA 
NDA Panel (2013)). 
CONCLUSIONS 
The Panel concluded that there is insufficient evidence to derive an Average Requirement (AR) and a 
Population Reference Intake (PRI) for molybdenum. Data on the relationship between molybdenum 
intakes and health outcomes were unavailable for the setting of DRVs for molybdenum. Thus, the 
Panel proposes an Adequate Intake (AI) for adults based on mean molybdenum intakes at the lower 
end of the range of observed intakes with mixed diets in the EU. It was considered unnecessary to 
give sex-specific values. The Panel suggests that the adult AI can be applied to pregnant and lactating 
women. An AI is also proposed for infants and children based on extrapolation from the adult AI 
using isometric scaling and the body weights of the respective age groups.  
Table 3:  Summary of Adequate Intake for molybdenum for infants, children and adults  
Age Adequate Intake 
(µg/day) 
  7-11 months 10 
  1-3   years 15 
  4-6   years 20 
  7-10 years 30 
11-14 years 45 
15-17 years 65 
≥ 18  years (a) 65 
(a):  Including pregnancy and lactation 
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APPENDICES  
APPENDIX A. MOLYBDENUM CONCENTRATION IN HUMAN MILK 
Reference Number of 
women 
(n of samples) 
Country Maternal 
intake (µg/day; 
mean ± SD) 
Stage of lactation Molybdenum concentration (µg/L) 
 
Mean ± SD                             Median 
 
 
Range (µg/L) 
Abdulrazzaq 
et al. (2008) 
205 United Arab 
Emirates 
Not reported 4-80 weeks 0.348  
 
0.061  0.001-1.9  
Anderson 
(1992) 
7 (84) USA Not reported Various times up to 
five months 
16.98 ± 0.97 (mean ± SE)   
Aquilio et 
al. (1996) 
8 [mothers of 
term infants] 
Italy Not reported 2-6 days 
12-16 days 
21 days 
6.8 ± 2.5 
5.7 ± 2.3 
3.6 ± 1.4 
  
Biego et al. 
(1998) 
17 France Not reported „Mature‟ 4 ± 3   
Bougle et al. 
(1988) 
6 [mothers of 
term infants] 
France Not reported 3-5 days 
7-10 days 
14 days 
1 month 
2 months 
10.2 ± 3.7 
  4.8 ± 3.9 
  1.5 ± 1.4 
  2.6 ± 2.2 
  0.2 (n = 1) 
  
Casey and 
Neville 
(1987) 
13 (62) USA Not reported 1
st
 day 
14 days 
1 month 
15.0 ± 6.1  
  4.5 ± 2.9  
~2  
 Day 2: 4.1-26.7  
Overall: 0.69-26.7  
Dang et al. 
(1984) 
6 
9 
8 
8 
India Not reported 3-5 days 
 
4-6 weeks 
12.1 ± 5.5 (middle income) 
10.8 ± 5.5 (low income) 
10.7 ± 3.4 (middle income) 
  7.2 ± 5.4 (low income) 
  
Friel et al. 
(1999) 
19 (152) Canada Not reported 1 week 
2 weeks 
4 weeks  
5-7 weeks 
 4  
3  
2  
1  
 
Gunshin et 
al. (1985) 
24 Japan Not reported 19-384 days 24  5-63 
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Reference Number of 
women 
(n of samples) 
Country Maternal 
intake (µg/day; 
mean ± SD) 
Stage of lactation Molybdenum concentration (µg/L) 
 
Mean ± SD                             Median 
 
 
Range (µg/L) 
Hattori et al. 
(2004) 
3 (17) Japan Not reported 96-327 days  4.5  2.0-8.8  
Krachler et 
al. (1998);  
Rossipal and 
Krachler 
(1998) 
46 (55) Austria Not reported 1-3 days 
4-17 days 
42-60 days 
66-90 days 
97-293 days 
8.88 ± 3.74  
5.1  
1.43 ± 1.77  
1.3 
1.78 ± 1.62  
9.00 
6.1 
1.02 
0.6 
1.56 
4.3-16 
1.2-27 
< 0.50-4.9 
< 0.50-3.5 
< 0.50-5.3 
Lopez-
Garcia et al. 
(2007) 
3 (15) Spain Not reported Not reported 2.9 ± 0.1 (volunteer 1) 
4.1 ± 0.1 (volunteer 2) 
0.7 ± 0.1 (volunteer 3) 
  
Pandey et al. 
(2003) 
241 India Not reported „Mature‟ 18 ± 4  7-60 
Sievers et al. 
(2004) 
19 (43) 
 
Germany Not reported   3.6 weeks (2.6-4.7)  
  8.4 weeks (7.3-10.1)  
15.9 weeks (15.3-16.6) 
1.1 ± 2.5 
3.9 ± 2.9 
2.1 ± 2.6 
  
Wappelhorst 
et al. (2002) 
19 (536) Germany, 
Poland, 
Czech 
Republic 
132 ± 60  
(Median: 125, 
analysis of food 
duplicates) 
3-68 weeks 0.72  0.53 0.27-1.62 
WHO/IAEA 
(1989); 
Parr et al. 
(1991) 
(335) Guatemala 
Hungary 
Nigeria 
Philippines 
Sweden 
Zaire 
Not reported 3 months  2.12 
< 0.3 
2.65 
16.36 
0.40 
1.39 
< 0.3-9.0 
< 0.3-3.9 
0.34-9.7 
6.75-35.4 
< 0.3-5.9 
< 0.3-5.8 
Yoshida et 
al. (2008) 
79 (79) Japan Not reported 5-191 days 5.42 ± 5.33 3.18  < 0.1-25.9 
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APPENDIX B. FOODS CONTRIBUTING TO MOLYBDENUM INTAKE IN THE UK, FRANCE, AND 
SWEDEN 
Miscellaneous 
cereals
33 %
Bread
19 %
Milk
7 %
Potatoes
6 %
Canned 
vegetables
6 %
Other vegetables
5 %
Meat product
4 %
Dairy products
4 %
Sugar and 
preserves
3 %
Green vegetables
3 %
Nuts
3 %
Beverages
2 % Poultry
1 %
Eggs
1 % Fresh fruits
1 %
Others
2 %
UK
 
Based on data from Rose et al. (2010) 
 
Bread and dried bread 
products
17 %
Vegetables (excluding 
potatoes)
9 %
Pulses
7 %
Fruits
6 %
Mixed dishes 
5 %
Pasta
4 %Milk
4 %
Ultra-fresh dairy 
products 
4 %
Alcoholic 
beverages
4 %
Rice and wheat 
products
3 %
Potatoes and 
potato products
3 %
Pastries and cakes
2 %
Cheese
2 %
Delicatessen meats
2 %
Dried fruits, 
nuts and seeds
2 %
Water
2 %
Pizzas, quiches 
and savoury 
pastries
2 %
Soups and broths
2 %
Others
17 %
France
Based on data from Anses (2011) 
Dietary Reference Values for molybdenum 
 
EFSA Journal 2013;11(8):3333 29 
Cereal products
51 %
Dairy products
16 %
Vegetables
10 %
Pastries
5 %
Meat
5 %
Potatoes
5 %
Sugar and sweets
4 %
Fruits
3 %
Eggs
1 %
Sweden
 
Based on data from NFA (2012) 
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APPENDIX C. MOLYBDENUM INTAKE IN CHILDREN AND ADULTS IN VARIOUS EUROPEAN COUNTRIES 
Country Age 
(years) 
Sex/ 
group 
n 
(subjects) 
Method Additional information Population/location Data source Mean SD Median Min P5 P95 P97.5 Max 
In µg/day 
Belgium   Adults  Duplicate 
portion 
study  
Duplicate meals, beverages and 
provision for between meals were 
collected over 24-h periods in four 
different settings in Belgium: 
Brussels (military academy), Antwerp 
(hospital), Vilvoorde (military service 
quarter), Liège (hospital). Sampling 
carried out for seven days 
consecutively between February and 
October 1992. 
Mean ± SD of the four sites Van Cauwenbergh 
et al. (1997) 
87.0 11.0             
     Antwerp  75.0 10.1  56.9    89.1 
     Brussels  99.0 15.6  74.9    125.3 
     Liège  79.0 14.4  66.4    110.2 
     Vilvoorde  93.1 74.3  45.6    257.6 
Denmark 30-34 Men 100 Duplicate 
diet study 
48-hour duplicate food portions (self-
selected diets, in March-May 1988). 
Subjects were asked to make records 
of all food and beverages consumed 
in a four-day period including one 
week-end day. During two of the four 
days, they were asked also to collect 
an exact duplicate of each item of 
food or beverage that had been 
consumed. 
Random sample among the 
population of 30-34 year old 
men in one urban (Odense, 
the third largest city in 
Denmark) and two rural 
areas 
Bro et al. (1990) 112.0 63.0 99.0 20.0       560.0 
Finland   Adults  Duplicate 
portion 
study 
Duplicated meals served in 11 
hospitals throughout Finland. Over 
seven consecutive days, diet 
duplicates included all meals, and 
meals were served to provide 
2 150 kcal/day. 
  Sinisalo et al. 
(1989) 
100.0 10.0   86.0       130.0 
Finland   Adults 
and 
children 
 Market 
basket 
study 
For 450 foods (raw, semi-processed 
or ready-made) commonly consumed 
in Finland, representative samples 
were analysed. No food preparation, 
processing or cooking before 
analyses. 
Method used to derive daily intake 
estimate not mentioned in this 
reference. 
  Varo and 
Koivistoinen 
(1980) 
120.0               
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Country Age 
(years) 
Sex/ 
group 
n 
(subjects) 
Method Additional information Population/location Data source Mean SD Median Min P5 P95 P97.5 Max 
France 3-17 Children 1 444 Total 
Diet 
Study 
2nd TDS (2007-2008). Analysed food 
samples from all the administrative 
regions of mainland France. A total of 
41 food groups, sub-divided in 212 
different types of foods were selected 
and sampled in at least one of 8 
regions, or at the national level, 
covering around 90 % of dietary 
consumption in the adult and child 
populations. Approximately 20 000 
food products were purchased in 
~thirty towns and prepared „as 
consumed‟, combined into 1 319 
composite samples, which were 
analysed by ICP-MS. Analytical 
results were combined with food 
consumption data from INCA2. 
Children, under-reporters 
excluded 
Anses (2011) 74.7       40.3 130.0     
 18-79 Adults 1 918  Adults, under-reporters 
excluded 
 93.9    49.1 154.9   
Germany 20-60 Men 28 
(n = 7 per 
location) 
Duplicate 
diet study 
In 1988, 1992 and 1996, the Mo 
consumption of healthy adults on 
mixed diets was investigated in 
different locations in Eastern 
Germany by means of duplicate 
portions studies at 11 regions in 
Eastern Germany. Each test group 
consisted of at least seven women and 
seven men. Recruited volunteers 
recorded all foods and beverages 
consumed during a three-day 
preliminary study to assess dietary 
habits. Seven women and seven men 
were randomly selected to participate 
in the study and collected a duplicate 
of each item of food or beverage that 
had been consumed during 24 hours, 
over seven subsequent days. 
Year 1988, in the following 
locations: Bad Langensalza 
and Jena in Thuringia, 
Vetschau and Wusterhausen 
in Brandenburg.  
Holzinger et al. 
(1998) 
74.0 62.0       
   42 
(n = 7 per 
location) 
 Year 1992, in the following 
locations: Bad Langensalza 
and Bad Liebenstein in 
Thuringia, Chemnitz and 
Freiberg in Saxony, 
Greifswald in Mecklenburg-
Western Pomerania, 
Wusterhausen in 
Brandenburg.  
 81.0 63.0       
   31 
 
  Year 1996, in the following 
locations: Jena, Ronneburg, 
Rositz, and Steudnitz in 
Thuringia.  
 100.0 66.0       
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Country Age 
(years) 
Sex/ 
group 
n 
(subjects) 
Method Additional information Population/location Data source Mean SD Median Min P5 P95 P97.5 Max 
  Women 28 
(n = 7 per 
location) 
  Year 1988, in the following 
locations: Bad Langensalza 
and Jena in Thuringia, 
Vetschau and Wusterhausen 
in Brandenburg.  
 58.0 36.0       
   42 
(n = 7 per 
location) 
  Year 1992, in the following 
locations: Bad Langensalza 
and Bad Liebenstein in 
Thuringia, Chemnitz and 
Freiberg in Saxony, 
Greifswald in Mecklenburg-
Western Pomerania, 
Wusterhausen in 
Brandenburg.  
 69.0 58.0       
   31   Year 1996, in the following 
locations: Jena, Ronneburg, 
Rositz, and Steudnitz in 
Thuringia.  
 89.0 98.0       
Italy   Adults  Modified 
Total 
Diet 
Study 
Choice of foods from the Italian 
Household National Survey (IHNS) 
1994-1996 (1 978 randomly selected 
subjects representative of the four 
main areas in Italy (North-West, 
North-East, Centre, South). Foods 
aggregated into six main groups. 
Most samples collected in a university 
cafeteria (raw, cooked, ready-to-eat), 
over two consecutive weeks in July 
2004 (n = 226 samples). Some 
traditional breakfast foods and a few 
foods included in the IHNS that were 
not served at the cafeteria were 
purchased at three local supermarkets 
(n = 22 samples). Samples were 
pooled and analysed and the content 
was multiplied by the average 
consumption by the North-West 
Italian adult population. 
Pavia (Northern Italy) Turconi et al. 
(2009) 
79.6     32.6       106.2 
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Country Age 
(years) 
Sex/ 
group 
n 
(subjects) 
Method Additional information Population/location Data source Mean SD Median Min P5 P95 P97.5 Max 
Sweden  Adults 
and 
children 
 Market 
basket 
study 
Collection of food baskets, in Uppsala 
in May-June 2010 (and in autumn for 
fruits, vegetables and potatoes), from 
five major Swedish grocery chains by 
using a shopping list based on per 
capita food consumption data derived 
from production and trade statistics; 
supplementary purchase statistics for 
fish and fats for 2009/2010. Market 
baskets divided into 12 food groups 
and analysed as purchased (n = 123 
samples). 
 NFA (2012) 157.0        
United 
Kingdom 
  Adults 
and 
children 
 Total 
Diet 
Study 
2006 UK TDS. Composite samples 
for 20 food groups (combined from 
119 food categories) collected from 
24 randomly selected UK towns, 
prepared and analysed by ICP-MS. 
Relative proportion of each food 
within a group reflected its 
importance in the average UK 
household diet. Consumption data of 
the food groups from the NDNS study 
were used. Exposures were estimated 
for the lower- and upper-bound 
concentrations and these have been 
included as ranges. 
 Rose et al. (2010) 123- 
125 
              
In µg/kg body weight per day 
United 
Kingdom 
1.5-4.5 Children  Total 
Diet 
Study  
2006 UK TDS. Composite samples 
for 20 food groups (combined from 
119 food categories) collected from 
24 randomly selected UK towns, 
prepared and analysed by ICP-MS. 
Relative proportion of each food 
within a group reflected its 
importance in the average UK 
household diet. Consumption data of 
the food groups from the NDNS study 
were used. Exposures were estimated 
for the lower- and upper-bound 
concentrations and these have been 
included as ranges. 
Toddlers  Rose et al. (2010) 4.80-
4.87 
          7.54-
8.32 
  
 4-18 Children   Older children   3.01-
3.05 
     5.77-
5.82 
 
 16-64 Adults     1.61-
1.64 
     3.03-
3.08 
 
 ≥ 65 Adults    Elderly, free living  1.43-
1.46 
     3.00-
3.03 
 
  ≥ 65 Adults     Elderly, institutional   1.33-
1.36 
          3.46-
3.54 
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ABBREVIATIONS 
Afssa Agence française de sécurité sanitaire des aliments 
AI Adequate Intake 
Anses Agence nationale de sécurité sanitaire de l‟alimentation, de 
l‟environnement et du travail 
AR Average Requirement 
COMA Committee on Medical Aspects of Food Policy 
CV Coefficient of variation 
D-A-CH Deutschland-Austria-Confoederatio Helvetica 
DoH Department of Health 
DRV Dietary Reference Value  
EAR Estimated Average Requirement 
EC European Commission 
EFSA European Food Safety Authority 
EU European Union 
FAO Food and Agriculture Organization 
FSANZ Food Standards Australia New Zealand 
IOM U.S. Institute of Medicine of the National Academy of Sciences 
ICP-MS Inductively coupled plasma mass spectrometry 
n Number 
NDNS National Diet and Nutrition Survey 
NFA National Food Agency 
NNR Nordic Nutrition Recommendations 
NOAEL No Observed Adverse Effect Level 
PRI Population Reference Intake 
RDA Recommended Dietary Allowance 
SCF Scientific Committee on Food 
SD Standard deviation 
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SE Standard error 
TDS Total Diet Study 
TPN Total Parenteral Nutrition 
UL Tolerable Upper Intake Level 
WHO World Health Organization 
 
